Insider · CIK 0001741836
Roger D Dansey
director
Files at INO (INOVIO PHARMACEUTICALS, INC.), NRIX (Nurix Therapeutics, Inc.), KRON (Kronos Bio, Inc.), BCYC (BICYCLE THERAPEUTICS PLC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | NRIX Nurix Therapeutics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 10, 2025 |
| Sep 8, 2025 | BCYC BICYCLE THERAPEUTICS PLC | AGrant or award Ordinary Shares | +12,500 | $0.00 | $0 | 12,500 | Sep 10, 2025 |
| Sep 8, 2025 | BCYC BICYCLE THERAPEUTICS PLC | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Sep 10, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -68,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,868 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -34,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,167 | - | - | 8,916 | May 21, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,167 | $0.00 | $0 | 0 | May 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.